Evidence map›Paper›PMID 37077218›Full record

ArticleNeurophotonics2023

Development of polarization-sensitive optical coherence tomography imaging platform and metrics to quantify electrostimulation-induced peripheral nerve injury

Guillermo L Monroy, Mohsen Erfanzadeh, Michael Tao, Damon T DePaoli, Ilyas Saytashev, Stephanie A Nam, Harmain Rafi, Kasey C Kwong, Katherine Shea, Benjamin J Vakoc and 2 more

Open access · goldAbstract read
In one paragraph

Article in Neurophotonics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Neurosurgical Intervention for Nerve and Muscle Biopsies.Diagnostics (Basel, Switzerland) · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

Guillermo L MonroyU. S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, Silver Spring, Maryland, United States.ORCID https://orcid.org/0000-0002-3669-8514
Mohsen ErfanzadehMassachusetts General Hospital, Harvard Medical School, Wellman Center for Photomedicine, Boston, Massachusetts, United States.ORCID https://orcid.org/0000-0001-6466-1009
Michael TaoU. S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, Silver Spring, Maryland, United States.
Damon T DePaoliMassachusetts General Hospital, Harvard Medical School, Wellman Center for Photomedicine, Boston, Massachusetts, United States.ORCID https://orcid.org/0000-0002-7882-323X
Ilyas SaytashevU. S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, Silver Spring, Maryland, United States.ORCID https://orcid.org/0000-0003-4213-1175
Stephanie A NamMassachusetts General Hospital, Harvard Medical School, Wellman Center for Photomedicine, Boston, Massachusetts, United States.ORCID https://orcid.org/0000-0002-6579-9007
Harmain RafiU. S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, Silver Spring, Maryland, United States.ORCID https://orcid.org/0000-0003-2113-3366
Kasey C KwongMassachusetts General Hospital, Harvard Medical School, Wellman Center for Photomedicine, Boston, Massachusetts, United States.
Katherine SheaU. S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Clinical Pharmacology, Office of Translational Science, Division of Applied Regulatory Science, Silver Spring, Maryland, United States.
Benjamin J VakocMassachusetts General Hospital, Harvard Medical School, Wellman Center for Photomedicine, Boston, Massachusetts, United States.ORCID https://orcid.org/0000-0002-6623-3515
Srikanth VasudevanU. S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, Silver Spring, Maryland, United States.ORCID https://orcid.org/0000-0001-6314-5328
Daniel X HammerU. S. Food and Drug Administration, Center for Devices and Radiological Health, Office of Science and Engineering Laboratories, Division of Biomedical Physics, Silver Spring, Maryland, United States.ORCID https://orcid.org/0000-0003-0532-1914
Harvard University · USOffice of Science · USUnited States Food and Drug Administration · USCenter for Devices and Radiological Health · USCenter for Drug Evaluation and Research · USMassachusetts General Hospital · US

Funding

TRD3: Percutaneous and Interstitial ImagingP41EB015903 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI Jacqueline Namati · 2012 to 2026
$22.4M
Novel optical coherence tomography tool development for quantitative peripheral nerve imagingOT2OD025306 · OD · MASSACHUSETTS GENERAL HOSPITAL · PI VAKOC, BENJAMIN JAMES · 2018 to 2020
$1.7M
NIBIB NIH HHS P41 EB015903NIH HHS OT2 OD025306
6 · The paper itself

Abstract

Significance: Neuromodulation devices are rapidly evolving for the treatment of neurological diseases and conditions. Injury from implantation or long-term use without obvious functional losses is often only detectable through terminal histology. New technologies are needed that assess the peripheral nervous system (PNS) under normal and diseased or injured conditions. Aim: We aim to demonstrate an imaging and stimulation platform that can elucidate the biological mechanisms and impacts of neurostimulation in the PNS and apply it to the sciatic nerve to extract imaging metrics indicating electrical overstimulation. Approach: A sciatic nerve injury model in a 15-rat cohort was observed using a newly developed imaging and stimulation platform that can detect electrical overstimulation effects with polarization-sensitive optical coherence tomography. The sciatic nerve was electrically stimulated using a custom-developed nerve holder with embedded electrodes for 1 h, followed by a 1-h recovery period, delivered at above-threshold Shannon model Results: The stimulation and imaging system successfully captured study data across the cohort. When compared to a SC after a 1-week recovery, the fascicle closest to the stimulation lead showed an average change of Conclusions: The poststimulation changes observed in our study are manifestations of nerve injury and repair, specifically degeneration and angiogenesis. Optical imaging metrics quantify these processes and may help evaluate the safety and efficacy of neuromodulation devices.

Indexed as

nerve stimulationneuromodulationoptical metricsperipheral nerve injurypolarization-sensitive optical coherence tomographyratsciatic nerve

Identifiers

PMID37077218
PMCPMC10109528
OpenAlexW4366140768

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.